Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-26-294828
Filing Date
2026-07-02
Accepted
2026-07-02 16:54:23
Documents
4

Document Format Files

Seq Description Document Type Size
1 424B5 d17914d424b5.htm 424B5 325737
2 GRAPHIC g17914g01x01.jpg GRAPHIC 57695
3 GRAPHIC g17914g21x21.jpg GRAPHIC 57693
4 GRAPHIC g17914g75p15.jpg GRAPHIC 83939
  Complete submission text file 0001193125-26-294828.txt   601710
Mailing Address 4 KINGSBURY AVENUE WATERTOWN MA 02472
Business Address 4 KINGSBURY AVENUE WATERTOWN MA 02472 617 607 0800
ENANTA PHARMACEUTICALS INC (Filer) CIK: 0001177648 (see all company filings)

EIN.: 043205099 | Fiscal Year End: 0930
Type: 424B5 | Act: 33 | File No.: 333-293390 | Film No.: 261152530
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)